Results 8,801-8,820 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: What is the criteria?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Yes.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: The NTPF is one half of the equation.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: The NTPF is one half of the equation that deals with public moneys, which is what we are interested in. Earlier, some points were made and it would be remiss of us not to put them to the NTPF.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: How does one decide? Let us say Marc MacSharry is in a nursing home in Sligo so it is what I get versus what Deputy Connolly gets in her nursing home in Galway, Dublin or wherever.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Let us say somebody, as mentioned earlier, borrowed €20 million to build a place but they should not have borrowed and overextended themselves. Is that kind of stuff taken into account? Is it just the operational costs that are taken into account when Mr. Horan says the NTPF considers the cost incurred evidence?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Am I correct to say that, regardless of whether a developer owes €100 million or nothing, the bodies concerned approach that aspect in the same way?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I understand. I get the picture that it is just in terms of the cost incurred.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: How can the price charged pre-2009 be relevant?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I know.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I know. In terms of a scheme, pricing pre-2009 is ten years ago.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: All right. Can the NTPF control the market price?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: If one looks at the price one paid last year to somebody else, it was the NTPF that paid the price so it is not a fair comparison, particularly if the NTPF is the only buyer in the market.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Right.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: The analysis is done against that backdrop. What is the realistic percentage?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: No. I just picked on that element because it looks a bit dodgy to me.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is all the required expertise available to the NTPF in terms of how much things should cost? I mean the cost per hour for so many staff, how much new beds cost, how much new equipment costs, etc.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Can the NTPF access information on independent pricing and all of that?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I appreciate that my next question does not fall within the remit of the NTPF but I shall ask it anyway given that the NTPF has the expertise. How can I reconcile someone paying €950 a week versus €1,400 a week? I am just taking advantage of the fact that there are experts in the room. I must ask about this matter because that is part of my role. Therefore, I am interested...
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: What is it in the private sector?